Cite

HARVARD Citation

    Wang, Y. et al. (2018). A novel functional polymorphism of GSTM3 reduces clear cell renal cell carcinoma risk through enhancing its expression by interfering miR‐556 binding. Journal of cellular and molecular medicine. 22 (6), pp. 3005-3015. [Online]. 
  
Back to record